Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Employment among patients with kidney disease remains low even after dialysis or a transplant, with physical and social ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

A team of researchers at UM have developed an innovative new tool that could transform how kidney disease is ...

A Diabetes, Heart Failure, and Kidney Disease Medication Is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes Feb. 11, 2025 — Over 1,000 genes may serve as possible ...

Raad B. Chowdhury, MD, and Shruti Gupta, MD, MPH, are onconephrologists in the Division of Nephrology at Brigham and Women's Hospital (BWH). They are first and senior authors, respectively, of a paper ...

Your kidneys are crucial in maintaining health by filtering waste, balancing body fluids, and regulating blood pressure.

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...

Johnson & Johnson's Invokana (canagliflozin) meanwhile also has an indication for diabetic kidney disease, but has been affected by side effect concerns which – while resolved – have sent its ...